Pfizer and PostEra collab in $250M AI lab deal

Jan 11, 2022

Related news

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Sep 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Paige Receives First Ever FDA Approval for AI Product in Digital Pathology

Oct 4
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Europe’s Early-Stage Life Sciences Venture Capitalists Unveil Advocacy Organisation to Drive Innovation and Investment in Health Care

Oct 4
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Coming Age for Tech x Bio: The “Industrial Bio Complex”

Nov 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Breakthrough science and the future of venture capital

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

French AI strategy: Tech sector to receive over €2 bln in next 5 years

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Exscientia Files For $100M IPO

Nov 10
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Cerebras Systems Raises $250M in Funding for Over $4B Valuation to Advance the Future of Artificial Intelligence Compute

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

European Biotech Investors Cap Off Record Year in Fundraising

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie